Stinson wins EMD and Merck assignment

Share this article:
Stinson Brand Innovation was awarded a global strategy assignment from EMD Biosciences and Merck Biosciences. Stinson will provide brand alignment and strategic planning services for EMD, a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem, Novabiochem and Novagen.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION